Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Max Healthcare Institute Ltd ( (IN:MAXHEALTH) ) has shared an announcement.
Max Healthcare Institute Ltd has announced the approval of a Scheme of Amalgamation between its wholly owned subsidiaries, Crosslay Remedies Limited and Jaypee Healthcare Limited. The National Company Law Tribunal, Chandigarh Bench, has sanctioned the merger, which is set to have an appointed date of October 5, 2024. This strategic move is expected to streamline operations and enhance the company’s market positioning, potentially benefiting stakeholders by creating a more unified and efficient healthcare service provider.
More about Max Healthcare Institute Ltd
Max Healthcare Institute Ltd operates in the healthcare industry, focusing on providing comprehensive healthcare services through its network of hospitals and healthcare facilities. The company is committed to delivering high-quality medical care and is a prominent player in the Indian healthcare market.
Average Trading Volume: 70,682
Technical Sentiment Signal: Buy
Current Market Cap: 1105.9B INR
See more insights into MAXHEALTH stock on TipRanks’ Stock Analysis page.